Skip to main content
Signal8

Protagonist Therapeutics Reports Granting of Inducement Awards

$PTGXPress releaseJun 16, 2026, 4:00 PM ETRead the release

Protagonist Therapeutics granted inducement awards to three new employees, consisting of options to purchase 14,800 shares and RSUs for 3,900 shares. The options have an exercise price of $112.46, equal to the closing price on the grant date, and vest over four years.

Key figures

Rsus awarded
3900
Exercise price
112.46
Options awarded
14800

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.